"A nausea medication or stool softener can mitigate these side effects but once you stop the GLP1 peptides, your appetite may ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

Rutgers scientists have uncovered a tug-of-war inside the brain between hunger and satiety, revealing two newly mapped neural ...

When Amy Kane started taking Mounjaro in 2022, she expected to lose weight − which she did, dropping more than 170 pounds.

Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys.

Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. These drugs have transformed the treatment of type 2 diabetes by helping lower blood sugar levels and even reducing the risk of ...

The two products accounted for about 48% of Eli Lilly's most recent quarterly sales and drove most of the top-line growth.

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

A 28-year-old man who started using the injectable medication on Saturday (7 June) has opened up on his experience so far ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...